Dihydroisotanshinone I and BMAL-SIRT1 Pathway in an In Vitro 6-OHDA-Induced Model of Parkinson’s Disease

Danshen has been widely used for the treatment of central nervous system diseases. We investigated the effect of dihydroisotanshinone I (DT), a compound extracted from Danshen, as well as the corresponding mechanisms in an in vitro-based 6-OHDA-induced Parkinson’s disease (PD) model. SH-SY5Y human n...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Hui-Chen, Sun, Yuan-Ting, Yang, Ming-Yu, Wu, Ching-Yuan, Hsu, Cheng-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341862/
https://www.ncbi.nlm.nih.gov/pubmed/37446264
http://dx.doi.org/10.3390/ijms241311088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341862/
https://www.ncbi.nlm.nih.gov/pubmed/37446264
http://dx.doi.org/10.3390/ijms241311088

Ejemplares similares